Ye J, Zhang J, Zhu Y, Wang L, Jiang X, Liu B
Acta Pharm Sin B. 2023; 13(12):4688-4714.
PMID: 38045051
PMC: 10692397.
DOI: 10.1016/j.apsb.2023.08.008.
Bjorklund G, Storchylo O, Peana M, Hangan T, Lysiuk R, Lenchyk L
Curr Med Chem. 2023; 31(41):6760-6774.
PMID: 37933215
DOI: 10.2174/0109298673252993230921073502.
Saha T, Lukong K
Front Oncol. 2022; 12:856974.
PMID: 35392236
PMC: 8979779.
DOI: 10.3389/fonc.2022.856974.
Aguilar-Gallardo C, Zamorano M, Farias J, de Aguiar Quevedo K
Mol Biol Rep. 2022; 49(7):6741-6751.
PMID: 35277787
DOI: 10.1007/s11033-022-07299-z.
Negi S, Chaudhuri A, Kumar D, Dehari D, Singh S, Agrawal A
Drug Deliv Transl Res. 2022; 12(11):2589-2612.
PMID: 35149969
DOI: 10.1007/s13346-022-01125-6.
Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives.
Ledys F, Kalfeist L, Galland L, Limagne E, Ladoire S
Cancers (Basel). 2021; 13(23).
PMID: 34885109
PMC: 8656936.
DOI: 10.3390/cancers13235999.
Understanding the Role of Autophagy in Cancer Formation and Progression Is a Real Opportunity to Treat and Cure Human Cancers.
Patergnani S, Missiroli S, Morciano G, Perrone M, Mantovani C, Anania G
Cancers (Basel). 2021; 13(22).
PMID: 34830777
PMC: 8616104.
DOI: 10.3390/cancers13225622.
The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy.
Yun C, Jeon J, Go G, Lee J, Lee S
Int J Mol Sci. 2020; 22(1).
PMID: 33375363
PMC: 7795059.
DOI: 10.3390/ijms22010179.
Targeting Autophagy in Breast Cancer.
Cocco S, Leone A, Piezzo M, Caputo R, Lauro V, Di Rella F
Int J Mol Sci. 2020; 21(21).
PMID: 33105796
PMC: 7660056.
DOI: 10.3390/ijms21217836.
Role of Autophagy in Cancer Cell Response to Nucleolar and Endoplasmic Reticulum Stress.
Pecoraro A, Pagano M, Russo G, Russo A
Int J Mol Sci. 2020; 21(19).
PMID: 33020404
PMC: 7582989.
DOI: 10.3390/ijms21197334.
Inhibition of VEGFA Increases the Sensitivity of Ovarian Cancer Cells to Chemotherapy by Suppressing VEGFA-Mediated Autophagy.
Li X, Hu Z, Shi H, Wang C, Lei J, Cheng Y
Onco Targets Ther. 2020; 13:8161-8171.
PMID: 32884298
PMC: 7443464.
DOI: 10.2147/OTT.S250392.
Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions.
Lee K, Chen G, Chen T, Kuo Y, Su Y
Cancers (Basel). 2020; 12(8).
PMID: 32751846
PMC: 7463650.
DOI: 10.3390/cancers12082122.
Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells.
Rahman M, Saha S, Rahman M, Uddin M, Uddin M, Pang M
Front Cell Dev Biol. 2020; 8:283.
PMID: 32391363
PMC: 7193248.
DOI: 10.3389/fcell.2020.00283.
The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation.
Hu F, Li G, Huang C, Hou Z, Yang X, Luo X
Cell Death Dis. 2020; 11(5):304.
PMID: 32358527
PMC: 7195408.
DOI: 10.1038/s41419-020-2467-3.
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Lee K, Kuo Y, Ho Y, Huang Y
Cancers (Basel). 2019; 11(9).
PMID: 31505803
PMC: 6769912.
DOI: 10.3390/cancers11091334.
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications.
Nazio F, Bordi M, Cianfanelli V, Locatelli F, Cecconi F
Cell Death Differ. 2019; 26(4):690-702.
PMID: 30728463
PMC: 6460398.
DOI: 10.1038/s41418-019-0292-y.
CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
Zhu J, Huang G, Hua X, Li Y, Yan H, Che X
Oncogene. 2019; 38(17):3301-3315.
PMID: 30635654
PMC: 7112719.
DOI: 10.1038/s41388-018-0664-7.
Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma.
Cao S, Huang Y, Zhang Q, Lu F, Donkor P, Zhu Y
Apoptosis. 2018; 24(1-2):33-45.
PMID: 30430397
DOI: 10.1007/s10495-018-1497-0.
Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms.
Visconte V, Przychodzen B, Han Y, Nawrocki S, Thota S, Kelly K
Leukemia. 2016; 31(2):505-510.
PMID: 27773925
PMC: 5844476.
DOI: 10.1038/leu.2016.295.
Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
Zhang L, Xu L, Zhang F, Vlashi E
Cell Cycle. 2016; 16(8):737-745.
PMID: 27753527
PMC: 5405729.
DOI: 10.1080/15384101.2016.1241929.